Stokes Family Office, LLC Charles River Laboratories International, Inc. Transaction History
Stokes Family Office, LLC
- $854 Million
- Q1 2025
A detailed history of Stokes Family Office, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Stokes Family Office, LLC holds 8,599 shares of CRL stock, worth $1.21 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
8,599
Previous 7,609
13.01%
Holding current value
$1.21 Million
Previous $1.4 Million
7.83%
% of portfolio
0.15%
Previous 0.16%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
651Shares Held
55.1MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$861 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$717 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$604 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$337 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$275 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.17B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...